BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27706810)

  • 1. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.
    Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y
    Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
    Urakawa H; Nishida Y; Wasa J; Arai E; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
    Int J Cancer; 2012 Jan; 130(2):454-66. PubMed ID: 21387290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.
    Nagase H; Kudo D; Suto A; Yoshida E; Suto S; Negishi M; Kakizaki I; Hakamada K
    Pancreas; 2017 Feb; 46(2):190-197. PubMed ID: 27846148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activity.
    Qin J; Kilkus J; Dawson G
    Biochim Biophys Acta; 2016 Feb; 1861(2):78-90. PubMed ID: 26548718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells.
    Saito T; Tamura D; Nakamura T; Makita Y; Ariyama H; Komiyama K; Yoshihara T; Asano R
    Oncol Rep; 2013 Jan; 29(1):335-42. PubMed ID: 23124556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of hyaluronan synthesis attenuates the tumorigenicity of low-grade chondrosarcoma.
    Hamada S; Nishida Y; Zhuo L; Shinomura T; Ikuta K; Arai E; Koike H; Kimata K; Ushida T; Ishiguro N
    J Orthop Res; 2018 Jun; 36(6):1573-1580. PubMed ID: 29091320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.
    Piccioni F; Malvicini M; Garcia MG; Rodriguez A; Atorrasagasti C; Kippes N; Piedra Buena IT; Rizzo MM; Bayo J; Aquino J; Viola M; Passi A; Alaniz L; Mazzolini G
    Glycobiology; 2012 Mar; 22(3):400-10. PubMed ID: 22038477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.
    Lokeshwar VB; Lopez LE; Munoz D; Chi A; Shirodkar SP; Lokeshwar SD; Escudero DO; Dhir N; Altman N
    Cancer Res; 2010 Apr; 70(7):2613-23. PubMed ID: 20332231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.
    Twarock S; Freudenberger T; Poscher E; Dai G; Jannasch K; Dullin C; Alves F; Prenzel K; Knoefel WT; Stoecklein NH; Savani RC; Homey B; Fischer JW
    Mol Cancer; 2011 Mar; 10():30. PubMed ID: 21429221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells.
    Tofuku K; Yokouchi M; Murayama T; Minami S; Komiya S
    Int J Oncol; 2006 Jul; 29(1):175-83. PubMed ID: 16773198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.
    Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S
    J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Methylumbelliferone Decreases the Hyaluronan-rich Extracellular Matrix and Increases the Effectiveness of 5-Fluorouracil.
    Yoshida E; Kudo D; Nagase H; Suto A; Shimoda H; Suto S; Kakizaki I; Endo M; Hakamada K
    Anticancer Res; 2018 Oct; 38(10):5799-5804. PubMed ID: 30275202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3.
    Kultti A; Pasonen-Seppänen S; Jauhiainen M; Rilla KJ; Kärnä R; Pyöriä E; Tammi RH; Tammi MI
    Exp Cell Res; 2009 Jul; 315(11):1914-23. PubMed ID: 19285976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
    Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
    Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan expression as a significant prognostic factor in patients with malignant peripheral nerve sheath tumors.
    Ikuta K; Urakawa H; Kozawa E; Arai E; Zhuo L; Futamura N; Hamada S; Kimata K; Ishiguro N; Nishida Y
    Clin Exp Metastasis; 2014 Aug; 31(6):715-25. PubMed ID: 24957185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expression.
    Tamura R; Yokoyama Y; Yoshida H; Imaizumi T; Mizunuma H
    J Ovarian Res; 2014 Oct; 7():94. PubMed ID: 25304388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo.
    Arai E; Nishida Y; Wasa J; Urakawa H; Zhuo L; Kimata K; Kozawa E; Futamura N; Ishiguro N
    Br J Cancer; 2011 Dec; 105(12):1839-49. PubMed ID: 22045192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumors.
    Ghadimi MP; Lopez G; Torres KE; Belousov R; Young ED; Liu J; Brewer KJ; Hoffman A; Lusby K; Lazar AJ; Pollock RE; Lev D
    Mol Cancer Ther; 2012 Aug; 11(8):1758-69. PubMed ID: 22848094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decorin suppresses stemness and migration potential of malignant peripheral nerve sheath tumor through inhibiting epidermal growth factor receptor signaling.
    Jia X; Chen L; Yu C
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167181. PubMed ID: 38653361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Effect of HDAC8 Inhibition in Malignant Peripheral Nerve Sheath Tumors.
    Lopez G; Pollock RE
    Methods Mol Biol; 2017; 1510():365-374. PubMed ID: 27761835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.